ES2121293T3 - Uso de trovafloxacina o derivados de la misma para la fabricacion de un medicamento para el tratamiento de infecciones por h. pylori. - Google Patents

Uso de trovafloxacina o derivados de la misma para la fabricacion de un medicamento para el tratamiento de infecciones por h. pylori.

Info

Publication number
ES2121293T3
ES2121293T3 ES95301959T ES95301959T ES2121293T3 ES 2121293 T3 ES2121293 T3 ES 2121293T3 ES 95301959 T ES95301959 T ES 95301959T ES 95301959 T ES95301959 T ES 95301959T ES 2121293 T3 ES2121293 T3 ES 2121293T3
Authority
ES
Spain
Prior art keywords
treatment
trovafloxacin
derivatives
manufacture
medicinal product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95301959T
Other languages
English (en)
Inventor
Arthur E Girard
Thomas D Gootz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Application granted granted Critical
Publication of ES2121293T3 publication Critical patent/ES2121293T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

UNA INFECCION CON "HELICOBACTER" PUEDE SER VENTAJOSAMENTE TRATADA POR UN COMPUESTO DE LA FORMULA (I) EN LA QUE R1 ES HIDROGENO O METIL; R2 ES HIDROGENO O L-ALANINA O L-ALANYL, ASI COMO LAS SALES FARMACOLOGICAMENTE ACEPTABLES DEL MISMO. LOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE ULCERAS GASTRICAS Y DUODENALES.
ES95301959T 1994-04-07 1995-03-23 Uso de trovafloxacina o derivados de la misma para la fabricacion de un medicamento para el tratamiento de infecciones por h. pylori. Expired - Lifetime ES2121293T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22439294A 1994-04-07 1994-04-07

Publications (1)

Publication Number Publication Date
ES2121293T3 true ES2121293T3 (es) 1998-11-16

Family

ID=22840476

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95301959T Expired - Lifetime ES2121293T3 (es) 1994-04-07 1995-03-23 Uso de trovafloxacina o derivados de la misma para la fabricacion de un medicamento para el tratamiento de infecciones por h. pylori.

Country Status (5)

Country Link
EP (1) EP0676199B1 (es)
AT (1) ATE170400T1 (es)
DE (1) DE69504392T2 (es)
DK (1) DK0676199T3 (es)
ES (1) ES2121293T3 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE19652239A1 (de) * 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
IN190017B (es) 1999-01-25 2003-05-31 Panacea Biotech Ltd
SE9904108D0 (sv) * 1999-11-15 1999-11-15 New Pharma Research Ab Nya föreningar
US6576625B2 (en) 2001-03-16 2003-06-10 Panacea Biotic Limited Targeted vesicular constructs for cytoprotection and treatment of H. pylori infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids

Also Published As

Publication number Publication date
ATE170400T1 (de) 1998-09-15
DE69504392D1 (de) 1998-10-08
EP0676199A1 (en) 1995-10-11
EP0676199B1 (en) 1998-09-02
DE69504392T2 (de) 1999-02-11
DK0676199T3 (da) 1999-02-08

Similar Documents

Publication Publication Date Title
CO4290353A1 (es) Agonistas de estrogeno
CY1108070T1 (el) Παραγωγα κινολινονης, ως αναστολεις κινασης τυροσινης
ES2123149T3 (es) Derivados de perhidroisoindol como antagonistas de la substancia p.
ES2174992T3 (es) Productos intermediarios para la obtencion de compuestos inhibidores de proteasas retrovirales.
ES2040838T3 (es) Compuestos piperazinil-heterociclicos.
ES2192201T3 (es) Compuestos de piranona utiles para el tratamiento de infecciones retrovirales.
ES2067248T3 (es) Derivados de indol como agentes antialergicos y antiinflamatorios.
PA8432901A1 (es) Compuestos de piridilpirrol
MX9305248A (es) Compuestos de diarilpiperazinoacetamida.
SE9702564D0 (sv) New compounds
ES2087625T3 (es) Derivados de ciclohexano sustituidos, procedimiento para su preparacion y el empleo de los compuestos para el tratamiento de enfermedades.
GT199900154A (es) Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas.
ATE132859T1 (de) 2-aminopyrimidin-4-carboxamid-derivate, deren herstellung und deren therapeutische anwendung
DE69302646D1 (de) Benzimidazolverbindungen als Antibiotika gegen Campylobacter pylon
AR003137A1 (es) Una composicion farmaceutica para tratar la leucemia
SE0003476D0 (sv) Compounds
ES2118945T3 (es) Derivados de melamina utilizados en el tratamiento del cancer.
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.
ES2163396T3 (es) Aminas biologicamente activas.
ES2135722T3 (es) 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina.
ES2121293T3 (es) Uso de trovafloxacina o derivados de la misma para la fabricacion de un medicamento para el tratamiento de infecciones por h. pylori.
ES2196069T3 (es) Derivados morfinoides condensados con heterociclos.
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.
ES2167721T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de la dermatitis seborreica.
PT861250E (pt) Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 676199

Country of ref document: ES